L&G Pharma Breakthrough UCITS ETF
ETLI.DE
#3140
ETF rank
ยฃ16.31 M
Marketcap
๐Ÿ‡ช๐Ÿ‡บ EU
Market
ยฃ11.06
Share price
0.31%
Change (1 day)
35.94%
Change (1 year)

Expense ratio and fees for L&G Pharma Breakthrough UCITS ETF (ETLI.DE)

Total Expense Ratio

Total Expense Ratio as of November 2025: 0.49%

ter

ter as of July 2026: 0.49%